SKL-27969
- Generic Name
- SKL-27969
- Drug Type
- Small Molecule
- CAS Number
- 2634762-24-4
- Unique Ingredient Identifier
- NVE35UH48R
Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- SK Life Science, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT05388435
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸Carolina BioOncology Institute, Huntersville, North Carolina, United States
🇺🇸START Midwest, Grand Rapids, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath